Jeff Szer
banner
marrow.bsky.social
Jeff Szer
@marrow.bsky.social
Haematologist with particular interests in BMT, PNH and Gaucher disease.
Reposted by Jeff Szer
Reposted by Jeff Szer
IMJ September 2025 #OpenAccess
Editor's Choice (Clinical Perspective): Medicinal cannabis: is current use clinically justified?
bit.ly/3K3qDDO
@theracp.bsky.social
bit.ly
September 12, 2025 at 4:00 AM
Reposted by Jeff Szer
IMJ September 2025 #FreeAccess
Review: Replacement therapy in congenital adrenal hyperplasia
bit.ly/3HF9KPi
@theracp.bsky.social
September 14, 2025 at 4:00 AM
Reposted by Jeff Szer
IMJ September 2025 #FreeAccess
Original Article: In-hospital cardiac arrest
bit.ly/4p5P8QZ
@theracp.bsky.social
September 15, 2025 at 4:01 AM
Reposted by Jeff Szer
IMJ September 2025 #FreeAccess
Original Article: Is incidence and burden of cancer increasing among young individuals?
bit.ly/4p88bdh
@theracp.bsky.social
bit.ly
September 16, 2025 at 4:00 AM
Reposted by Jeff Szer
IMJ September 2025 #OpenAccess
Original Article: Automatic screening for viral hepatitis in an Emergency Department
bit.ly/46h53EB
@theracp.bsky.social
bit.ly
September 17, 2025 at 4:00 AM
Reposted by Jeff Szer
IMJ September 2025 #FreeAccess
Original Article: Lung transplantation for interstitial lung diseases
bit.ly/3JELX2B
@theracp.bsky.social
bit.ly
September 18, 2025 at 4:00 AM
Reposted by Jeff Szer
IMJ October 2025 #OpenAccess
Editor's Choice (Clinical Perspective): Hyperhidrosis: don’t sweat it
bit.ly/42uVLmg
@theracp.bsky.social
October 14, 2025 at 3:00 AM
Reposted by Jeff Szer
IMJ October 2025 #FreeAccess
Editorial: A, B, C or D? Goals of Care: a need for a national structural framework.
bit.ly/46JpvOI
@theracp.bsky.social
October 15, 2025 at 3:01 AM
A bumper issue of @the-imj.bsky.social Congratulations.
October 13, 2025 at 9:23 AM
Reposted by Jeff Szer
September 11, 2025 at 3:37 AM
Reposted by Jeff Szer
IMJ August 2025 #FreeAccess
Editor's Choice (Original Article): Glomerular disease registry and Biobank
bit.ly/3ULSydE
@theracp.bsky.social @marrow.bsky.social @sunilbadve.bsky.social
August 15, 2025 at 4:00 AM
Reposted by Jeff Szer
IMJ August 2025 #OpenAccess
Original Article: Hyperuricaemia in Type 1 Gaucher disease
bit.ly/3Hl6zMi
@theracp.bsky.social @marrow.bsky.social
August 21, 2025 at 4:00 AM
Reposted by Jeff Szer
Reposted by Jeff Szer
IMJ July 2025 #OpenAccess
Editor's choice (review): Generative artificial intelligence in healthcare
bit.ly/4loWVXS
@theracp.bsky.social
GenAI in clinical healthcare could be transformative. However, numerous challenges exist including technological, regulatory, workforce adaption, and trust.
July 12, 2025 at 4:00 AM
Reposted by Jeff Szer
IMJ July 2025 #FreeAccess
Editorial: Are Australians Living with Dementia Ready for New Therapies?
bit.ly/4eEYE8M
@theracp.bsky.social
July 13, 2025 at 4:00 AM
Reposted by Jeff Szer
IMJ July 2025 #OpenAccess
Original Article: Alzheimer disease: rollout of amyloid-targeting therapies
bit.ly/3Il89Oq
@theracp.bsky.social
bit.ly
July 14, 2025 at 4:01 AM
Reposted by Jeff Szer
IMJ July 2025 #FreeAccess
Clinical Perspective: Management of pulmonary fibrosis
bit.ly/3IkW7EO
@theracp.bsky.social
New research is expanding pulmonary fibrosis treatment beyond IPF to other fibrotic ILDs, integrating targeted drugs and immunomodulation.
July 15, 2025 at 4:01 AM
Reposted by Jeff Szer
IMJ July 2025 #OpenAccess
Original article: ‘No man's land’ – transition to adulthood for young adults with complex health needs
bit.ly/4nITRaC
@theracp.bsky.social
bit.ly
July 16, 2025 at 4:01 AM
Reposted by Jeff Szer
IMJ July 2025 #OpenAccess
Original Article: Terminal heart failure care for women
bit.ly/44UDDDH
@theracp.bsky.social
bit.ly
July 17, 2025 at 4:01 AM
Reposted by Jeff Szer
IMJ July 2025 #OpenAccess
Original Article: Allogeneic haemopoietic stem cell transplantation for patients with chronic lymphocytic leukaemia
bit.ly/3Iltfw0
@theracp.bsky.social
bit.ly
July 18, 2025 at 4:01 AM
Reposted by Jeff Szer
Reposted by Jeff Szer
Want to learn about the prevention of thrombosis in patients with PNH?🩸

Make sure to watch our recent interview from #IPIG2025 with @marrow.bsky.social‬ of @petermaccc.bsky.social‬ in which he discusses this:

🎥 buff.ly/i8Ry0Zr

#RareDisease #Hematology #Thrombosis #BloodSky #MedSky
June 9, 2025 at 4:05 PM
Reposted by Jeff Szer
IMJ June 2025 #FreeAccess
Editorial: "Two decades at the helm: it only seems like a few weeks". Former Editor-in-Chief (now Emeritus Editor) Jeff Szer looks back at his many years on the IMJ.
bit.ly/3FNAg86
@theracp.bsky.social
@marrow.bsky.social
June 14, 2025 at 4:00 AM
Reposted by Jeff Szer
IMJ May 2025 #OpenAccess
Editor's choice (clinical perspective): Chimeric antigen-T cells and bispecific antibodies
bit.ly/3Z3Hrj1
@theracp.bsky.social @marrow.bsky.social
May 16, 2025 at 4:00 AM